Meeder Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1K | Buy |
31
+5
| +19% | +$1.63K | ﹤0.01% | 613 |
|
|
2025
Q1 | $7.02K | Sell |
26
-12
| -32% | -$3.24K | ﹤0.01% | 708 |
|
|
2024
Q4 | $8.94K | Buy |
38
+1
| +3% | +$235 | ﹤0.01% | 726 |
|
|
2024
Q3 | $10.2K | Sell |
37
-284
| -88% | -$78.1K | ﹤0.01% | 613 |
|
|
2024
Q2 | $78K | Buy |
321
+297
| +1,238% | +$72.2K | 0.01% | 287 |
|
|
2024
Q1 | $3.59K | Buy |
+24
| New | +$3.59K | ﹤0.01% | 680 |
|
|
2022
Q4 | – | Sell |
-56
| Closed | -$11K | – | 829 |
|
|
2022
Q3 | $11K | Buy |
56
+8
| +17% | +$1.57K | ﹤0.01% | 1289 |
|
|
2022
Q2 | $7K | Sell |
48
-15
| -24% | -$2.19K | ﹤0.01% | 1490 |
|
|
2022
Q1 | $10K | Buy |
+63
| New | +$10K | ﹤0.01% | 1530 |
|
|
2021
Q4 | – | Sell |
-5,104
| Closed | -$964K | – | 1157 |
|
|
2021
Q3 | $964K | Buy |
5,104
+5,037
| +7,518% | +$951K | 0.05% | 280 |
|
|
2021
Q2 | $11K | Sell |
67
-1
| -1% | -$164 | ﹤0.01% | 1649 |
|
|
2021
Q1 | $10K | Sell |
68
-15
| -18% | -$2.21K | ﹤0.01% | 1594 |
|
|
2020
Q4 | $11K | Sell |
83
-4,878
| -98% | -$646K | ﹤0.01% | 953 |
|
|
2020
Q3 | $722K | Sell |
4,961
-544
| -10% | -$79.2K | 0.05% | 288 |
|
|
2020
Q2 | $816K | Sell |
5,505
-1,538
| -22% | -$228K | 0.05% | 277 |
|
|
2020
Q1 | $766K | Sell |
7,043
-7,342
| -51% | -$799K | 0.06% | 254 |
|
|
2019
Q4 | $1.66M | Buy |
14,385
+13,202
| +1,116% | +$1.52M | 0.1% | 177 |
|
|
2019
Q3 | $95K | Sell |
1,183
-160
| -12% | -$12.8K | 0.01% | 818 |
|
|
2019
Q2 | $97K | Buy |
1,343
+1,001
| +293% | +$72.3K | 0.01% | 767 |
|
|
2019
Q1 | $32K | Buy |
342
+263
| +333% | +$24.6K | ﹤0.01% | 962 |
|
|
2018
Q4 | $6K | Buy |
+79
| New | +$6K | ﹤0.01% | 1360 |
|
|
2018
Q3 | – | Sell |
-249
| Closed | -$24.5K | – | 1523 |
|
|
2018
Q2 | $24.5K | Sell |
249
-562
| -69% | -$55.4K | ﹤0.01% | 917 |
|
|
2018
Q1 | $97K | Sell |
811
-1,608
| -66% | -$192K | 0.01% | 551 |
|
|
2017
Q4 | $307K | Buy |
2,419
+2,003
| +481% | +$254K | 0.03% | 408 |
|
|
2017
Q3 | $49K | Buy |
416
+327
| +367% | +$38.5K | 0.01% | 687 |
|
|
2017
Q2 | $7K | Buy |
+89
| New | +$7K | ﹤0.01% | 1078 |
|
|
2016
Q3 | – | Sell |
-3,160
| Closed | -$175K | – | 748 |
|
|
2016
Q2 | $175K | Buy |
+3,160
| New | +$175K | 0.02% | 584 |
|